{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:31:29Z","timestamp":1772807489424,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1211,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1998,9]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>To compare the effects of ranitidine 75\u2003mg with those of either cimetidine 200\u2003mg or placebo given on demand for relief of typical symptoms of gastro\u2010oesophageal reflux disease during a 15\u2010day period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A total of 1336 patients (aged \u2265\u200318\u2003years) with heartburn episodes were recruited and randomly assigned to a ranitidine 75\u2003mg, cimetidine 200\u2003mg or placebo group. Depending on the occurrence or persistence of heartburn, treatment was administered as required up to three times daily, with at least 2\u2003h between drug doses. Antacids were allowed as rescue medication if symptoms persisted for at least 2\u2003h after the third medication on any given day. The primary end\u2010point was defined as the proportion of patients with relief of at least 75% of heartburn episodes during the study period (i.e. relief occurring within 2\u2003h after drug ingestion and lasting for at least 5\u2003h).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Analysis was performed in an intention\u2010to\u2010treat population comprising 504 subjects in the ranitidine group, 515 in the cimetidine group and 270 in the placebo group. Primary end\u2010point success rates were 41, 38 and 28%, respectively, for the three groups (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.001 for ranitidine vs. placebo, <jats:italic>P\u2003<\/jats:italic>=\u20030.274 for ranitidine vs. cimetidine). Ranitidine 75\u2003mg was significantly more effective than placebo in providing overall heartburn relief (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.001). The differences between the ranitidine and cimetidine groups were not significant, except for a greater reduction in heartburn frequency in the ranitidine group at the end of the study period (<jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05). Drug dose was lower and less rescue medication was used in the ranitidine group than the placebo group<jats:bold>. <\/jats:bold>The three treatment groups did not differ in terms of tolerability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>On\u2010demand ranitidine 75\u2003mg or cimetidine 200\u2003mg are safe and effective treatment for reflux\u2010related symptoms.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1998.00384.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:37:03Z","timestamp":1047353823000},"page":"909-917","source":"Crossref","is-referenced-by-count":33,"title":["On\u2010demand treatment of gastro\u2010oesophageal reflux symptoms: a comparison of ranitidine 75\u2003mg with cimetidine 200\u2003mg or placebo"],"prefix":"10.1111","volume":"12","author":[{"given":"J. P.","family":"Galmiche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Casset\u2010Semanaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,6,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"721","article-title":"Douleurs \u00e9pigastriques et r\u00e9gurgitations: \u00e9pid\u00e9miologie descriptive dans un \u00e9chantillon repr\u00e9sentatif de la population fran\u00e7aise adulte","volume":"12","author":"Bruley des Varannes S","year":"1988","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.4.401"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01071906"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90287-F"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/13814789509161628"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00073.x"},{"key":"e_1_2_6_8_2","unstructured":"CastellDO.Introduction to physiopathology of gastroesophageal reflux. In: Castell DO Wu WC Ott DJ eds. Gastroesophageal Reflux Disease: Pathogenesis Diagnosis Therapy. New York: Futura Publishing Company 1985: 3\u20139."},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1155\/1992\/780530","article-title":"Canadian consensus conference on the treatment of gastroesophageal reflux disease","volume":"6","author":"Beck IT","year":"1992","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_6_10_2","unstructured":"GalmicheJP JanssensJ MainguetP VantrappenG eds. Le traitement du reflux gastro\u2010oesophagien et de l\u2032oesophagite peptique. In: Reflux gastro\u2010oesophagien et oesophagite peptique. Amsterdam: Excepta Medica 1994: 117\u201340."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.11.1523"},{"key":"e_1_2_6_12_2","article-title":"Ranitidine in the management of symptoms of GORD in primary care","volume":"106","author":"Houston LJ","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.1987.00370080123022","article-title":"Ranitidine therapy for gastroesophageal reflux disease. Results of a large double\u2010blind trial","volume":"147","author":"Sontag S","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199505000-00003"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00115.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.3.294"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)23703-8"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1991.tb00020.x"},{"key":"e_1_2_6_19_2","first-page":"48","article-title":"A comparison of intragastric acidity following low doses of ranitidine and cimetidine","volume":"39","author":"Hamilton MR","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1996.00440050019003","article-title":"The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment. Suggested disease management guidelines","volume":"156","author":"Fennerty MB","year":"1996","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_21_2","first-page":"577","article-title":"Critical issues in the management of gastroesophageal reflux disease","volume":"7","author":"Freston JW","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_22_2","first-page":"527","article-title":"Control of gastric acid secretion. Histamine H2\u2010receptor antagonist and H+K(+)\u2010ATP axe inhibitors","volume":"21","author":"Shamburek RD","year":"1992","journal-title":"Gastroenterol Clin North Am"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199106020-00002"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.136312000.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00384.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00384.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1998.00384.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:49:20Z","timestamp":1695869360000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1998.00384.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1046\/j.1365-2036.1998.00384.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1998.00384.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}